Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Effects of dopamine-like drugs on rat striatal adenyl cyclase have implications for CNS dopamine receptor topography

Nature volume 250, pages 238–241 (1974)Cite this article

Abstract

THE involvement of central dopaminergic neurones in the pathogenesis of several extrapyramidal movement disorders is well documented1,2. Moreover it has been suggested that dopaminergic mechanisms may also be involved in the physiological mechanisms underlying psychoses3. For these reasons there is considerable neuropharmacological interest in the interaction between anti-Parkinsonian and neuroleptic drugs and central dopaminergic systems. Recently it has been shown that homogenates of tissues containing dopaminergic synapses respond to low concentrations of dopamine by an increased production of cyclic AMP. These areas include the bovine superior cervical ganglion4, the rat and bovine retina5, rat basal ganglia6, olfactory tubercle, nucleus accumbens7 and cortex8. The effects of dopamine in some of these systems are mimicked by dopamine receptor stimulating drugs such as apomorphine6,7 and 1-(3,4-dihydroxybenzyl)-4-(2-pyrimidyl) piperazine (S584)9 and antagonised by neuroleptic drugs6,10–12. It seems, therefore, that these systems represent valid models of CNS dopamine receptors and it has been suggested that they may even comprise the dopamine receptor itself6. We have studied the dopamine-sensitive adenyl cyclase of the rat striatum in order to define some of the structural requirements for dopamine receptor agonists.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Klawans, H. L., jun., The Pharmacology of Extrapyramidal Movement Disorders (Karger, Basel, 1973).

    Google Scholar 

  2. Carlsson, A., Acta neurol. scand., suppl. 51, 11–42 (1972).

    CAS  Google Scholar 

  3. Matthysse, S., Fedn. Proc., 32, 200–205 (1972).

    Google Scholar 

  4. Greengard, P., McAfee, D. A., and Kebabian, J. W., in Advances in cyclic nucleotide research vol. 5, 337–357 (Raven Press, New York, 1972).

    Google Scholar 

  5. Brown, J. H., and Makman, M. H., Proc. natn. Acad. Sci. U.S.A., 69, 539–543 (1972).

    Article  ADS  CAS  Google Scholar 

  6. Kebabian, J. W., Petzold, G. L., and Greengard, P., Proc. natn. Acad. Sci. U.S.A., 69, 2145–2149 (1972).

    Article  ADS  CAS  Google Scholar 

  7. Horn, A. S., Cuello, A. C., and Miller, R. J., J. Neurochem., 22, 265–270 (1974).

    Article  CAS  Google Scholar 

  8. Von Hungen, H., and Roberts, S., Eur. J. Biochem., 36, 391–401 (1973).

    Article  CAS  Google Scholar 

  9. Miller, R. J., and Iversen, L. L., Naunyn-Schmiedebergs Arch. exp. Path. Pharmac., 282, 213–216 (1974).

    Article  CAS  Google Scholar 

  10. Miller, R. J., and Iversen, L. L., Trans. Biochem. Soc., 2, 256–259 (1974).

    CAS  Google Scholar 

  11. Miller, R. J., and Iversen, L. L., J. Pharm. Pharmac., 26, 142–144 (1974).

    Article  CAS  Google Scholar 

  12. Brown, J. H., and Makman, M. H., J. Neurochem., 21, 477–479 (1973).

    Article  CAS  Google Scholar 

  13. Klein, D. F., and Davis, J. M., in Diagnosis and Treatment of Psychiatric Disorders, 74 (Williams and Wilkins, Baltimore, 1969).

    Google Scholar 

  14. Goldberg, L. I., Sanneville, P. F., and NcNay, J. L., J. Pharmac. exp. Ther., 163, 188–197 (1968).

    CAS  Google Scholar 

  15. Woodruff, G. N., and Walker, R. J., Int. J. Neuropharmac., 8, 279–289 (1969).

    Article  CAS  Google Scholar 

  16. Bergin, R., and Carlstrom, D., Acta Cryst., B 24, 1506–1510 (1968).

    Article  CAS  Google Scholar 

  17. Bustard, T. M., and Egan, R. S., Tetrahedron, 27, 4457–4469 (1971).

    Article  CAS  Google Scholar 

  18. Giesecke, J., Acta Cryst., B 29, 1785–1791 (1973).

    Article  CAS  Google Scholar 

  19. Rekker, R. F., Engel, D. J. C., and Nys, G. C., J. Pharm. Pharmac., 24, 589–591 (1972).

    Article  CAS  Google Scholar 

  20. Kier, L. B., and Truitt, E. B., J. Pharmac. exp. Ther., 174, 94–98 (1970).

    CAS  Google Scholar 

  21. Horn, A. S., and Snyder, S. H., Proc. natn. Acad. Sci. U.S.A., 68, 2325–2328 (1971).

    Article  ADS  CAS  Google Scholar 

  22. Cannon, J. G., Kim, J. C., Aleem, M. A., and Long, J. P., J. med. Chem., 15, 348–350 (1972).

    Article  CAS  Google Scholar 

  23. Woodruff, G. N., Comp. Gen. Pharmac., 2, 43P (1971).

    Article  Google Scholar 

  24. Pinder, R. M., Buxton, D. A., and Woodruff, G. N., J. Pharm. Pharmac., 24, 903–904 (1972).

    Article  CAS  Google Scholar 

  25. Glowinski, J., and Iversen, L. L., J. Neurochem., 13, 655–669 (1966).

    Article  CAS  Google Scholar 

  26. Brown, B. L., Ekins, R. D., and Albano, J. D. M., in Advances in cyclic nucleotide research, vol. 2 (edit. by Greengard, P., and Robinson, G. A.), 25–40 (Raven Press, New York, 1972).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. MRC Neurochemical Pharmacology Unit, Department of Pharmacology, Medical School, Hills Road, Cambridge, CB2 2QD, UK

    RICHARD MILLER, ALAN HORN & LESLIE IVERSEN

  2. Chemical Defence Establishment, Porton Down, Salisbury, Wiltshire, UK

    ROGER PINDER

Authors
  1. RICHARD MILLER
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. ALAN HORN
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. LESLIE IVERSEN
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. ROGER PINDER
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

MILLER, R., HORN, A., IVERSEN, L. et al. Effects of dopamine-like drugs on rat striatal adenyl cyclase have implications for CNS dopamine receptor topography. Nature 250, 238–241 (1974). https://doi.org/10.1038/250238a0

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1038/250238a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing